High adoption rate of home kits for diagnosis of HIV and increasing investment by private as well as government organizations to develop effective diagnostic techniques are factors driving growth of the HIV diagnostics market.
High adoption rate of home kits for diagnosis of HIV and increasing investment by private as well as government organizations to develop effective diagnostic techniques are factors driving growth of the HIV diagnostics market
The global HIV diagnostics market size is expected to reach USD 7.62 Billion in 2028 and register a CAGR of 10.1% over the forecast period, according to the latest report by Reports and Data. HIV diagnostics market revenue growth is driven by increasing prevalence of the diseases and surge in risk of AIDS in developing countries.
According to WHO, around 38 million individuals across the globe were living with HIV infection in 2019. Due to various initiatives taken by government and international organizations, 68% of adults and 53% of children infected by the virus are receiving lifelong Antiretroviral Therapy (ART). Presence of favorable government initiatives and reimbursement policies are also key factors driving market revenue growth. Advancements in HIV testing technologies and increased focus on safe blood transfusions are other factors also propelling growth of the market.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4134
Research have proven that early diagnosis and treatment of HIV can reduce suffering, limit HIV-related illnesses, and prevent transmission to others. Surge in prevalence of HIV infection and rise in expenditure for research & development by healthcare companies will continue to fuel HIV diagnostic market growth. Increase in HIV antigen, viral load testing, nucleic acid testing, and remunerative growth opportunities will further contribute to the growth of the market going ahead. However, lack of proper regulatory framework for Nucleic Acid Testing (NAT) in developing countries and high associated costs are some major factors restraining market growth to some extent.
Some Key Highlights From the Report
- In April 2021, Atomo Diagnostics Limited and Viatris Inc. announced a multi-year agreement with Unitaid, which is a global health agency, to expand access to HIV self-testing in low- and middle-income countries. The Mylan HIV Self-Test, designed and manufactured by Atomo, is prequalified by WHO and detects the presence or absence of HIV antibodies in a small blood sample obtained from a fingertip.
- Antibody tests segment dominated other segments in the category in 2020 as these tests can determine if a person is infected with HIV between 3–12 weeks after infection. One of the antibody tests is Radio-immunoprecipitation Assay (RIPA), which was developed to detect antibodies of HIV-1. These assays have the advantage of fast turnaround, quantitation, and versatility.
- Consumable segment revenue is driven by steady increase in purchase of these products by hospitals and laboratories, and increase in initiatives by governments to fight AIDS/HIV. Consumables are also used to collect, prepare, and examine patient samples such as tissue, blood, fluids, and others.
- Diagnostic labs segment accounted for largest revenue share in 2020 due to increase in number of diagnostic centers to test for HIV infection, particularly in third-world countries. Moreover, HIV tests are mandatory during pregnancy, which is also fueling growth of this segment. High investment in R&D and advancements in technology are also contributing to revenue growth of the diagnostic labs segment.
- North America accounted for largest revenue share in the global HIV diagnostics market in 2020 due to established and advanced healthcare infrastructure and services, and presence of key market players such as Thermo-Fisher Scientific Inc., Becton, Dickinson & Company and Bio-Rad Laboratories, among others. High investment in research & development of rapid testing kits for HIV is also contributing significantly to market revenue growth.
- Major players in the market include Abbott Laboratories, Becton, Dickinson & Company, Siemens Healthineers, Beckman Coulter, Inc., Hologic Inc., Roche Diagnostics, Thermo-Fisher Scientific Inc., Bio-Rad Laboratories, Bristol-Myers Squibb, and Gilead Sciences.
To know more about the report @ https://www.reportsanddata.com/report-detail/hiv-diagnostics-market
For the purpose of this report, Reports and Data has segmented the global HIV diagnostics market based on product, test type, end-use, and region:
Product Outlook (Revenue, USD Billion; 2018–2028)
- Consumables
- Assays and Kits & Reagents
- Other Consumables
- Instruments
- Software & Services
Test Type Outlook (Revenue, USD Billion; 2018–2028)
- Antibody Tests
- HIV-1 Screening Tests
- ELISA
- Rapid Tests
- Home Access Dried Blood Spot
- HIV-1 Confirmatory Tests
- Western Blot Tests
- Indirect Immune Fluorescent Antibody Assays (IFA)
- Line Immunoassays (LIA)
- Radio-Immunoprecipitation Assays (RIPA)
- HIV-2 & Group O Diagnostic Tests
- HIV-1 Screening Tests
- Viral Load Tests
- CD4 Tests
- Tests for Early Infant Diagnosis
- Tests for Viral Identification
End-use Outlook (Revenue, USD Billion; 2018–2028)
- Diagnostic Laboratories
- Hospitals
- Blood Banks
- Home Care Settings
Buy Premium Research Report @ https://www.reportsanddata.com/checkout-form/4134
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- BENELUX
- Switzerland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/4134
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data's
Sheath Introducer Market by Product Type (Straight Sheaths, Curved Sheaths), By End-use (Hospitals, Clinics, Ambulatory Surgical Centers), and By Region Forecast to 2028
Open Surgery Heart Valves Market Size, Share And Analysis By Valve Type (Tissue and Mechanical), By Procedure Type (Open Surgery, Minimally Invasive Surgery (MIS)), By End-Use (Hospital, Clinic, and Others), and By Region Forecast to 2028
Vessel Sealing Devices Market By Product (Generators, Instruments, Accessories), By Procedure Type (Laparoscopic, Open Surgery), By Technology (LigaSure Technology, PlasmaKinetic Technology, Harmonic Scalpel, Ligamax 5 Technology, EnSeal Technology, Others), By Application, By Energy (Bipolar, Ultrasonic, Hybrid, Others), By End-use, and By Region, Forecast to 2028
Atropine Market , By Product Type (Injection, Drop, Gel), By Application (Gastrointestinal, Ophthalmology, Others), and By Region Forecast to 2028
Tinea Pedis Treatment Market , By Disease Type (Interdigital Tinea Pedis, Plantar Tinea Pedis, Vesicular Tinea Pedis), By Route of Administration (Oral and Topical [Gel, Creams, Spray, Lotions, and Powders]), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-Commerce), and By Region Forecast to 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-hiv-diagnostics-market